December 8, 2021

Arunachal Front

Complete News World

European agency EMA recommends adding a side effect – RT in French

The European Pharmaceutical Institute has recommended the inclusion of rare types of spinal cord inflammation and cross myelitis in the list of side effects of the Govit-19 vaccine developed by Johnson & Johnson.

On November 11, the European Pharmaceuticals Association (EMA) recommended adding a side effect le Vaccine Anti Govit Johnson & Johnson (J&J).

A spokesman for the U.S. Laboratory announced that the pamphlet ‘s side effects of the vaccine will be updated to include the risk of cross-sectional myelitis, a rare neurological disorder caused by inflammation of the spine.

The Commission has also evaluated cases of Capillary League Syndrome (CLS) as part of improving its vaccine safety recommendations following the administration of the Covit-19 vaccine developed by Moderna.

The EMA says it has been notified of eight cases of CLS, but it is not yet known whether there is a causal link between these cases and vaccination.

Capillary league syndrome is a very rare and serious condition that causes fluid leakage from small blood vessels (capillaries), resulting in swelling, hypotension, thickening of the blood and low levels of albumin (an important blood protein) in the EMA.

Data on this pathology were reviewed after administration of Astrogenogen and J&J vaccines.

The EMA added that there is currently insufficient evidence of a possible link between multisystem inflammatory syndrome (MIS) and rare cases known as messenger MRNA vaccines. , Pfizer and Moderna.

MIS is a serious but rare disease that causes inflammation in various parts of the body such as the heart, lungs, kidneys, brain, skin, eyes or gastrointestinal tract. J&J and Moderna did not immediately respond to requests for comment from Reuters.

See also  Shot in Larisis in front of his family